Evidence map›Paper›PMID 40261489›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Monitoring of the oncological process for lung cancer in Spain: an expert consensus report.

Javier de Castro, Patricia Alonso-Fernández, José Javier Castrodeza, Ángel Gayete, Florentino Hernando, José Martínez-Olmos, Bartomeu Massuti, Luis Paz-Ares, Antoni Sisó-Almirall, David Vicente and 1 more

Abstract readConsensus Statement
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Recommendations for the development of an integrated lung cancer care process: an expert consensus report.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Javier de CastroDepartment of Medical Oncology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain. javier.decastro@salud.madrid.org.ORCID http://orcid.org/0000-0002-3622-6306
Patricia Alonso-FernándezDepartment of Admissions, Hospital Clínico San Carlos, Madrid, Spain.
José Javier CastrodezaDepartment of Preventive Medicine, Hospital Clínico Universitario de Valladolid, Castilla y León, Valladolid, Spain.
Ángel GayeteDepartament of Diagnostic Radiology, Hospital del Mar de Barcelona, Cataluña, Barcelona, Spain.
Florentino HernandoDepartment of Thoracic Surgery, Hospital Clínico San Carlos, Madrid, Spain.
José Martínez-OlmosEscuela Andaluza de Salud Pública (EASP), Andalucía, Spain.
Bartomeu MassutiDepartment of Medical Oncology, Hospital General Universitario de Alicante, Valencia, Spain.
Luis Paz-AresDepartment of Medical Oncology, Hospital Universitario 12 Octubre, Madrid, Spain.
Antoni Sisó-AlmirallConsorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Cataluña, Barcelona, Spain.
David VicenteDepartment of Medical Oncology, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain.
Laureano MolinsDepartment of Thoracic Surgery, Hospital Clínic, Barcelona University, Cataluña, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionContinuous monitoring of the oncological process is essential for identifying inefficiencies and areas of improvement, enabling better resource allocation in the care of lung cancer patients.

objectiveThe objective is to define key indicators and identify critical variables for monitoring lung cancer care, aiming to improve early detection, reduce delays in diagnosis and treatment, and enhance biomarker research, ensuring timely and effective treatments for all patients.

methodsA multidisciplinary expert group conducted a consensus process based on a review of national guidelines and initiatives related to lung cancer care. The experts defined relevant indicators and identified variables for monitoring overall care, addressing delays, and improving biomarker research. The feasibility of incorporating these indicators into existing information systems was also assessed.

resultsThe proposed indicators provide a structured approach for assessing lung cancer care and outcomes. Their inclusion in healthcare information systems would improve the monitoring and evaluation of care quality and patient outcomes. Additionally, these indicators would also promote interoperability and continuous patient care across different centers and regions, allowing informed decision-making in the improvement of healthcare processes by those responsible for healthcare management.

conclusionsThe adoption of standardized indicators for lung cancer care monitoring can drive continuous improvement in healthcare processes. Implementing these indicators in information systems will enable better resource allocation, timely and effective treatment, and enhanced coordination among healthcare providers, ultimately improving patient outcomes.

Indexed as

Lung NeoplasmsConsensusHumansPractice Guidelines as TopicQuality Indicators, Health CareSpainIndicatorsInteroperabilityLung cancerMonitoringOncological processQuality

Identifiers

PMID40261489
PMCPMC12460426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.